IMF Videos Search Content For Healthcare Professional (122) Healthcare Provider (122) Care Partner (75) Patient (74) Series - Any - ASCO/EHA (49) ASH (60) Ask Dr. Durie (16) Black Swan Research Initiative (5) Community Workshops (4) Emerging Therapies (6) Facebook Live (10) Health Equity (2) IMWG (3) Inspirational (3) Living Well with Myeloma (4) Myeloma in a Minute (1) Myeloma Made Simple (3) Patient & Family Webinar (4) Q&A (7) Recent News and Developments (4) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (65) High-Risk Myeloma (42) High-risk Smoldering Myeloma (34) Late Relapse (4–6 Lines of Therapy) (81) MGUS (35) Newly Diagnosed (Pre-Treatment or First Treatment) (64) Smoldering Myeloma (50) Types of Therapy Immunomodulatory drugs (IMiDs) (58) Immunotherapies (CAR T; BiTE, etc.) (93) Monoclonal antibodies (48) Proteasome inhibitors (43) Stem cell transplant (40) Steroids (41) Supportive Care (36) Year Published 2026 (16) 2025 (38) 2024 (58) 2023 (39) 2022 (10) 2021 (7) 2020 (1) 2019 (9) 2018 (2) 2017 (1) 2016 (3) Trusted Voices Dr. Joseph Mikhael (36) Dr. Brian GM Durie (15) Dr. María-Victoria Mateos (6) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (5) Dr. Saad Usmani (3) Dr. Sigurður Kristinsson (3) Dr. Shaji Kumar (2) Dr. Urvi A. Shah (2) Dr. Sagar Lonial (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Analysis of treatment efficacy in the GEM-CESAR trial for high-risk smoldering multiple myeloma patients June 11, 2020 ASCO/EHA La espectrometría de masa Qip en pts con MM de alto riesgo latente incluidos en el ensayo GEM-CESAR December 13, 2019 ASH Estrategia curativa (GEM-CESAR) para el mieloma latente de alto riesgo (SMM) December 11, 2019 ASH Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM) December 11, 2019 ASH What is a BEAT? November 20, 2019 Ask Dr. Durie Will it be possible to prevent multiple myeloma? September 19, 2019 Ask Dr. Durie Living Well: Sorting Out the Approach to Relapse September 9, 2019 Living Well with Myeloma How CRISPR Could Impact the Future of Myeloma Treatment March 5, 2019 Emerging Therapies The Black Swan Research Initiative Moves Ever Closer to a Cure for Myeloma February 11, 2019 Black Swan Research Initiative Two-Year Follow-Up of the IMF's iStopMM (Iceland Screens Treats or Prevents Myeloma) February 6, 2019 Black Swan Research Initiative Clinical Trials in Myeloma November 1, 2018 Living Well with Myeloma Curative Strategy for High-Risk Smoldering Myeloma (GEM-CESAR) January 3, 2018 ASH Load More
